EYOB TESSEMA: Open Payments
NPI 1639195076 · ENTERPRISE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,136 in 68 payments from 12 companies in 2025. Trend: 2023 $1,094 · 2024 $1,601 · 2025 $1,136
Food & beverage: $1,136
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 17 | $290 |
| Alkermes, Inc. | 9 | $193 |
| Tris Pharma Inc | 14 | $161 |
| Otsuka America Pharmaceutical, Inc. | 10 | $152 |
| ABBVIE INC. | 7 | $130 |
| Collegium Pharmaceutical, Inc. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Corium, LLC | 1 | $30 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
Products named: FANAPT, ARISTADA, REXULTI, Dyanavel XR, VRAYLAR, Jornay PM, CAPLYTA, Auvelity.
Industry payments across AL — which companies pay providers there.
